X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (28) 28
middle aged (25) 25
female (23) 23
adult (22) 22
aged (22) 22
male (22) 22
oncology (20) 20
chemotherapy (18) 18
hematology (18) 18
life sciences (17) 17
lymphomas (16) 16
cancer (14) 14
rituximab (14) 14
prognosis (13) 13
adolescent (12) 12
[ sdv.can ] life sciences [q-bio]/cancer (11) 11
aged, 80 and over (11) 11
lymphoma (11) 11
[sdv.can]life sciences [q-bio]/cancer (10) 10
fluorodeoxyglucose f18 (9) 9
positron-emission-tomography (9) 9
disease (8) 8
hodgkin lymphoma (8) 8
prospective studies (8) 8
survival analysis (8) 8
analysis (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
care and treatment (7) 7
fdg-pet (7) 7
follow-up studies (7) 7
non-hodgkins-lymphoma (7) 7
radiopharmaceuticals (7) 7
young adult (7) 7
abridged index medicus (6) 6
medicine & public health (6) 6
patients (6) 6
positron-emission tomography - methods (6) 6
predictive value of tests (6) 6
response assessment (6) 6
transplantation (6) 6
trial (6) 6
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
cyclophosphamide (5) 5
disease-free survival (5) 5
hemic and lymphatic diseases (5) 5
immunotherapy (5) 5
multivariate analysis (5) 5
nuclear medicine (5) 5
stem cells (5) 5
survival (5) 5
therapy (5) 5
toxicity (5) 5
antibodies, monoclonal, murine-derived - administration & dosage (4) 4
autografts (4) 4
cardiology (4) 4
diffuse large b-cell lymphoma (4) 4
doxorubicin (4) 4
early f-18-fdg pet (4) 4
hodgkin disease - diagnostic imaging (4) 4
hodgkin disease - drug therapy (4) 4
hodgkin disease - pathology (4) 4
hodgkin's disease (4) 4
imaging / radiology (4) 4
lymphoma, large b-cell, diffuse - diagnostic imaging (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
lymphoma, large b-cell, diffuse - therapy (4) 4
non-hodgkin-lymphoma (4) 4
open-label (4) 4
orthopedics (4) 4
pet imaging (4) 4
radiology, nuclear medicine & medical imaging (4) 4
retrospective studies (4) 4
tomography (4) 4
treatment outcome (4) 4
tumor burden (4) 4
tumors (4) 4
vincristine (4) 4
clinical-features (3) 3
cyclophosphamide - administration & dosage (3) 3
doxorubicin - administration & dosage (3) 3
follow-up (3) 3
france - epidemiology (3) 3
immune system diseases (3) 3
immunophenotype (3) 3
international workshop (3) 3
lymphom (3) 3
lymphoma, large b-cell, diffuse - diagnosis (3) 3
lymphoma, large b-cell, diffuse - mortality (3) 3
medicine, general & internal (3) 3
mortality (3) 3
neoplasm staging (3) 3
pet (3) 3
pet/ct (3) 3
prednisone (3) 3
prednisone - administration & dosage (3) 3
safety (3) 3
stem cell transplantation (3) 3
survival rate (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bulletin du Cancer, ISSN 0007-4551, 02/2017, Volume 104, Issue 2, pp. 182 - 194
Classical Hodgkin lymphoma (HL) is a curable disease in 80% of advanced and 90% of localized stages. An improvement of the HL curability is still possible with... 
Hodgkin Lymphoma | Brentuximab vedotin | Immunological checkpoint inhibitor | PET-CT
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 30, pp. 3618 - 3626
Purpose Identifying patients at high risk of progression and early death among those with high-tumor-burden follicular lymphoma (FL) is unsatisfactory with... 
FDG-PET | SURVIVAL | IMMUNOCHEMOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | CYCLOPHOSPHAMIDE | RESPONSE ASSESSMENT | VINCRISTINE | NON-HODGKIN-LYMPHOMA | R-CVP | PROGNOSTIC VALUE
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2014, Volume 41, Issue 11, pp. 2017 - 2022
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2019, Volume 20, Issue 4, pp. e190 - e190
Journal Article
Journal Article
Blood, ISSN 0006-4971, 05/2018, Volume 131, Issue 22, pp. 2449 - 2453
Both total metabolic tumor volume (TMTV), computed on baseline positron emission tomography (PET), and end of induction (EOI) PET are imaging biomarkers... 
POOLED ANALYSIS | RISK | HEMATOLOGY | VOLUME
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2018, Volume 36, Issue 28, pp. 2845 - 2853
PurposeOutcomes for patients with diffuse large B-cell lymphoma remain heterogeneous, with existing methods failing to consistently predict treatment failure.... 
FDG-PET | SURVIVAL | INTERIM | CONSOLIDATION | THERAPY | ONCOLOGY | END-POINT | HODGKIN | CHEMOTHERAPY | TRANSPLANTATION | ORIGINAL REPORTS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7, pp. 805 - 806
Journal Article
Journal Article